Literature DB >> 32205561

Increased dipeptidyl peptidase-4 accelerates chronic stress-related thrombosis in a mouse carotid artery model.

Xianglan Jin1, Chunzi Jin1, Kae Nakamura2, Tiefeng Jin3, Minglong Xin1, Ying Wan1, Xueling Yue1, Shengyu Jin4, Hailong Wang1, Aiko Inoue5, Yongshan Nan1, Zhenhua Lin3, Masafumi Kuzuya5, Xian Wu Cheng1.   

Abstract

OBJECTIVE: Exposure to chronic psychosocial stress is a risk factor for metabolic cardiovascular disorders. Given that dipeptidyl peptidase-4 (DPP-4) has an important role in human pathobiology, we investigated the role of DPP-4 in stress-related thrombosis in mice, focusing on oxidative stress and the von Willebrand factor (vWF)-cleaving protease ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13). METHODS AND
RESULTS: Male mice randomly assigned to nonstress and 2-week immobilized-stress groups underwent iron chloride3 (FeCl3)-induced carotid artery thrombosis surgery for morphological and biochemical studies at specific times. On day 14 post-stress/surgery, stress had enhanced the lengths and weights of arterial thrombi, with alterations of plasma DPP-4, plasminogen activation inhibitor-1 and ADAMTS13. The stressed mice had increased levels of vascular cell adhesion molecule-1, intracellular adhesion molecule-1, monocyte chemoattractant protein-1, gp91phox, p22phox, matrix metalloproteinase-2 (MMP-2), MMP-9, cathepsins S and K mRNAs and/or proteins, and reduced levels of endothelial nitric oxide synthase, catalase and superoxide dismutase-1 mRNAs and/or proteins. Stress also accelerated arterial endothelial cell damage. The DPP-4 inhibitor anagliptin ameliorated the stress-induced targeted molecular and morphological changes and thrombosis. In vitro, DPP-4 inhibition also mitigated the alterations in the targeted ADAMTS13 and other oxidative and inflammatory molecules in human umbilical vein endothelial cells in response to H2O2.
CONCLUSION: DPP-4 inhibition appeared to improve the FeCl3-induced thrombosis in mice that received stress, possibly via the improvement of ADAMTS13 and oxidative stress, suggesting that DPP-4 could become a novel therapeutic target for chronic psychological stress-related thrombotic events in metabolic cardiovascular disorders.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32205561     DOI: 10.1097/HJH.0000000000002418

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Cathepsin K Deficiency Prevented Kidney Damage and Dysfunction in Response to 5/6 Nephrectomy Injury in Mice With or Without Chronic Stress.

Authors:  Xueling Yue; Limei Piao; Hailong Wang; Zhe Huang; Xiangkun Meng; Takeshi Sasaki; Aiko Inoue; Kae Nakamura; Ying Wan; Shengnan Xu; Guo-Ping Shi; Weon Kim; Toyoaki Murohara; Masafumi Kuzuya; Xian Wu Cheng
Journal:  Hypertension       Date:  2022-06-21       Impact factor: 9.897

Review 2.  Role of Neuroimmune Interactions in COVID-19-related Cardiovascular Damage.

Authors:  Xing Chen; Wei-Hua Qiao; Hong Cao; Jia-Wei Shi; Xin-Ling Du; Nian-Guo Dong
Journal:  Curr Med Sci       Date:  2022-06-08

3.  Linagliptin Regulates the Mitochondrial Respiratory Reserve to Alter Platelet Activation and Arterial Thrombosis.

Authors:  Yi Li; Rong Li; Ziqian Feng; Qin Wan; Jianbo Wu
Journal:  Front Pharmacol       Date:  2020-11-30       Impact factor: 5.810

Review 4.  Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases.

Authors:  Wei Peng; Rui Zhou; Ze-Fang Sun; Jia-Wei Long; Yong-Qiang Gong
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

Review 5.  DPP4 as a Potential Candidate in Cardiovascular Disease.

Authors:  Si-Yu Chen; Xiang-Quan Kong; Ke-Fan Zhang; Shuai Luo; Feng Wang; Jun-Jie Zhang
Journal:  J Inflamm Res       Date:  2022-09-16

6.  A Novel Dipeptidyl Peptidase-4 Inhibitor DA-1229 Ameliorates Tubulointerstitial Fibrosis in Cyclosporine Nephrotoxicity in Mice.

Authors:  Hye Sook Min; Ji Eun Lee; Jung Yeon Ghee; Young Sun Kang; Jin Joo Cha; Jee Young Han; Sang Youb Han; Dae Ryong Cha
Journal:  Life (Basel)       Date:  2021-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.